Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Cayman Chemical Triflusal, Purity: ≥98%, CAS: 322-79-2, 10 mg
SDP

Catalog No. 502992482
Encompass_Preferred

A platelet aggregation inhibitor (IC50s = 48.3 and 693 µM in isolated human whole blood and platelet-rich plasma, respectively); inhibits arachidonic acid-induced TXB2 and PGF1α production (IC50s = 468 and 339 µM, respectively); decreases IgG-ovalbumin immune complex-induced NF-κB nuclear translocation and NO production in isolated rat peritoneal macrophages at 1,000 µM; reduces infarct volume and peri-infarct levels of OX-6 in a rat model of focal ischemia induced by permanent MCAO at 30 mg/kg; reduces increases in APP levels induced by amyloid-β (25-35) in rats at 30 mg/kg

Catalog No. 50-299-2482 Supplier Cayman Chemical Supplier No. 3027410 MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

A platelet aggregation inhibitor (IC50s = 48.3 and 693 µM in isolated human whole blood and platelet-rich plasma, respectively); inhibits arachidonic acid-induced TXB2 and PGF1α production (IC50s = 468 and 339 µM, respectively); decreases IgG-ovalbumin immune complex-induced NF-κB nuclear translocation and NO production in isolated rat peritoneal macrophages at 1,000 µM; reduces infarct volume and peri-infarct levels of OX-6 in a rat model of focal ischemia induced by permanent MCAO at 30 mg/kg; reduces increases in APP levels induced by amyloid-β (25-35) in rats at 30 mg/kg

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.